PMC9389358_01
Computed tomography (CT) scan of the chest. (A) There are lesions of infiltrates under the pleura of the right lung when the patient is admitted. (B) After 2 weeks of antibiotic therapy, countercheck thoracic CT shows that pulmonary infiltrates are not significantly absorbed and appear to spread to the left lung and lower in the right. (C) The infiltrations under the pleura in both lungs were basically absorbed after a mouth of corticosteroid therapy.
fmed-09-942237-g001.jpg
PMC9389358_02_fmed-09-942237-g001.jpg
F1
Three months later, the patient was asymptomatic, and the thoracic CT scan showed that the pulmonary infiltrations had resolved (Figure 1C).
Pathological changes of lung tissue: microscopic finding of the right lower lung shows a heavy eosinophilic infiltration, > 20 eosinophils per high power field (H and E, x400).
fmed-09-942237-g002.jpg
PMC9389358_01_fmed-09-942237-g002.jpg
F2
No positive bacteria were detected by special staining (Figure 2).
PMC9389358_02
Computed tomography (CT) scan of the chest. (A) There are lesions of infiltrates under the pleura of the right lung when the patient is admitted. (B) After 2 weeks of antibiotic therapy, countercheck thoracic CT shows that pulmonary infiltrates are not significantly absorbed and appear to spread to the left lung and lower in the right. (C) The infiltrations under the pleura in both lungs were basically absorbed after a mouth of corticosteroid therapy.
fmed-09-942237-g001.jpg
PMC9389358_02_fmed-09-942237-g001.jpg
F1
Three months later, the patient was asymptomatic, and the thoracic CT scan showed that the pulmonary infiltrations had resolved (Figure 1C).
Changes in the condition after vedolizumab (VDZ) therapy. VDZ, vedolizumab; LVEF, levofloxacin; CTX, cefotaxime; CT, computed tomography; EBUS, endobronchial ultrasound.
fmed-09-942237-g003.jpg
PMC9389358_02_fmed-09-942237-g003.jpg
F3
For changes in the condition after VDZ therapy, refer to Figure 3.